Skip to main content
OpenTrials

Clinical trial condition

High Risk Stage III Melanoma

Explore clinical trials studying High Risk Stage III Melanoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

High Risk Stage III Melanoma trial results

Completed

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

NCT00636168

Conditions
High Risk Stage III Melanoma
Locations
  • The Angeles Clinic & Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • North. Cal. Melanoma Center-St. Mary's Medical Center San Francisco, California, United States
View all 97 locations
View Trial Details